Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2019 Dec 20;38:500. doi: 10.1186/s13046-019-1501-8

Correction to: LncMAPK6 drives MAPK6 expression and liver TIC self-renewal

Guanqun Huang 1,#, Hui Jiang 2,#, Yueming He 2, Ye Lin 3, Wuzheng Xia 3, Yuanwei Luo 1, Min Liang 2, Boyun Shi 2, Xinke Zhou 2,, Zhixiang Jian 3,
PMCID: PMC6923974  PMID: 31861994

Correction to: J Exp Clin Cancer Res

https://doi.org/10.1186/s13046-018-0770-y

In the original publication of this article [1], the author found an error in Fig. 2f. lncGPR107 should be changed to lncMAPK6, and the corrected Fig. 2 is shown below.

Fig. 2.

Fig. 2

LncMAPK6 is overexpressed in liver tumor and TICs. a MAPK6 locus was shown. There is a divergent lncRNA (ENST00000561318, termed as lncMAPK6 in this research) in near from MAPK6 locus according to UCSC Genome Browser. b LncMAPK6 expression levels were detected using Northern blot. 18S rRNA was a loading control. c 19 peri-tumor, 7 eHCC and 12 aHCC were used for In situ hybridization (ISH). Representative photos and indicated ratios were shown. d LncMAPK6 expression levels in CD133+ liver TICs and CD133 non-TICs were detected by realtime PCR, and non-TIC expression was used for data normalization. e Spheres and non-spheres were selected, and lncMAPK6 expression was examined with realtime PCR. f, g FISH assay confirmed the high expression of lncMAPK6 in liver TICs (f) and oncospheres (g). Zic2 and CD133 were markers of liver TICs. Scale bars, C, 50 μm; F, 20 μm

The author sincerely apologizes for the inconvenience caused to the readers.

Footnotes

Guanqun Huang and Hui Jiang contributed equally to this work.

Contributor Information

Xinke Zhou, Email: nihaeoj1465@126.com.

Zhixiang Jian, Email: sdf1984365@126.com.

Reference


Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES